Your academic institution may have purchased access to content. Find your institution below and we'll take you to your institution's login page
Login here to access an Administrator account for an institution, a personal subscription or to manage your alerts.
Receive monthly Table of Contents alerts from The Bone & Joint Journal
Comprehensive article alerts can be set up and managed through your account settings
View my account settings
The optimal method of prophylaxis against venous thromboembolism after total hip replacement (THR) remains uncertain. Most surgeons use some form of pharmacological prophylaxis, most commonly heparin. The precise balance of the benefits and risks is unclear, and serious complications can occur. We describe a case of heparin-induced thrombocytopenia and thrombosis syndrome in a 62-year-old woman after THR.
Downloaded 164 times
